[1]
2017. Selective Safety Data Collection in Clinical Studies of Oncology Drugs for Marketing Approval in the United States. Journal of Regulatory Science. 5, 2 (Aug. 2017), 36–44. DOI:https://doi.org/10.21423/JRS-V05N02P029.